Stigmatization of people with psoriasis
Keywords:
discrimination, quality of life, psoriasis, stigmatizationAbstract
Psychodermatologic disorders are conditions involving an interaction between the skin and the mind. Understanding the psychosocial and occupational context of skin diseases is critical for the optimal management of psychodermatological disorders.
The problem of social stigmatization is characterized in the paper. Psoriasis is a chronic, recurrent, inflammatory disease, which affects 1-3% of the population. In the course of the disease skin lesions are often extensive and causing disfiguring of the patients. Psoriasis can be regarded socially excluding stigmata. Stigmatization is a common problem to overcome for people suffering from chronic diseases.
The basic theoretical assumptions of the stigmatization are presented in the paper. Stigmatization can be recognized if there is a concurrence of labeling, stereotypy, exclusion, emotional reactions, loss of social status and discriminations.
Stigmatization accompanies patients all the time, influences their families, social and occupational life. Social stigmatization and discrimination of person with psoriasis is a common problem.
The presence of chronic disease and associated visible skin changes significantly affect the psychosocial functioning of patients, and contribute to reducing social contacts and the deterioration of social and living conditions. We are still looking for new therapies that could reduce the tremendous negative impact on the mental state of psoriasis patients. Taking into account the social context of psoriasis is essential to effective treatment.
References
1. Richards HL, Fortune DG, Griffiths CE, Main CJ. The contribution of perceptions of stigmatisation to disability in patients with psoriasis. J Psychosom Res. 2001;50(1):11-5.
2. Finkelstein J, Lapshin O, Wasserman E. Randomized study of diffe- rent anti-stigma media. Patient Educ Couns. 2008;71(2):204-14.
3. Schmid-Ott G, Schallmayer S, Calliess IT. Quality of life in patients with psoriasis and psoriasis arthritis with a special focus on stigmati- zation experience. Clin Dermatol. 2007;25(6):547-54.
4. Magin P, Adams J, Heading G, Pond D, Smith W. The psychological sequelae of psoriasis: results of a qualitative study. Psychol Health Med. 2009;14(2):150-61.
5. Ronda L, Jones L. Treating severe psoriasis: an update. Nurs Stand. 2005;20(4):57-65;
6. Schmid-Ott G, Künsebeck HW, Jecht E, Shimshoni R, Lazaroff I, Schallmayer S, Calliess IT, Malewski P, Lamprecht F, Götz A. Stigma- tization experience, coping and sense of coherence in vitiligo patients. J Eur Acad Dermatol Venereol. 2007;21(4):456-61.
7. Kimball AB, Jacobson C, Weiss S, Vreeland MG, Wu Y. The psycho- social burden of psoriasis. Am J Clin Dermatol. 2005;6(6):383-92.
8. Schmid-Ott G, Malewski P, Kreiselmaier I, Mrowietz U. Psychosocial consequences of psoriasis – an empirical study of disease burden in 3753 affected people. Hautarzt. 2005;56(5):466-72.
9. Aberer E, Riedl A. Stigmatization. Consideration from a theological- dermatologic perspective. Hautarzt. 2004;55(12):1168-71.
10. Schmid-Ott G, Burchard R, Niederauer HH, Lamprecht F, Künsebeck HW. Stigmatization and quality of life of patients with psoriasis and atopic dermatitis. Hautarzt. 2003;54(9):852-7.
11. Scambler G, Heijnders M, van Brakel WH. Understanding and tackling health-related stigma. Psychol Health Med. 2006;11(3):269-70.
12. Scambler G. Health-related stigma. Sociol Health Illn. 2009;31(3): 441-55.
13. Scambler G. Sociology, social structure and health-related stigma. Psychol Health Med. 2006;11(3):288-95.
14. Somma D, Bond V. International research workshop on health-related stigma and discrimination. Psychol Health Med. 2006;11(3):271-6.
15. Vardy D, Besser A, Amir M, Gesthalter B, Biton A, Buskila D. Experi- ences of stigmatization play a role in mediating the impact of disease severity on quality of life in psoriasis patients. Br J Dermatol. 2002; 147(4):736-42.
